相关实验视频
Updated: Jan 9, 2026

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
81.8K
肺结核中抗利芬辛的流行:一个基于实验室的研究
Israel Bedzina1, Agnes Naa Larley Lartey2, Lois Kwaley-Buabeng2
1Fly Zipline Ghana Limited, Kete-Krachi, Oti Region, Ghana.
PLOS global public health
|December 1, 2025
概括
加纳的结核病 (TB) 患病率为9.1%,男性和年轻人的患病率更高. 在1.8%的病例中发现了利芬辛耐药性,这突显了改善结核病监测和早期检测的必要性.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 结核病 (TB) 是一个主要的全球卫生问题,由耐药菌株加剧.
- 关于加纳的Mycobacterium结核病 (MTB) 患病率和抗利芬素耐药性的数据有限.
- 设施级数据对于有针对性的结核病控制战略至关重要.
研究的目的:
- 在霍教学医院的假定结核病例中确定MTB和利芬素耐药性的患病率.
- 分析与结核病感染和耐药性相关的人口因素.
- 为加纳国家结核病控制计划提供设施级数据.
主要方法:
- 使用2022-2024年的二次数据进行回顾性研究设计.
- 来自霍教学医院微生物学实验室的2225个假定结核病例的分析.
- 使用GeneXpert MTB/RIF测定方法识别MTB和利芬素耐药性.
主要成果:
- 结核病总体患病率为9.1% (203/2,225),男性 (12.4%) 和年轻成年人 (18-24岁,12.8%) 的患病率明显高.
- 在1.8% (3/166) 的MTB阳性病例中检测到里芬辛耐药性.
- 在人口群体之间没有观察到抗药性流行率的统计学上显著差异.
结论:
- 这项研究为霍教学医院的结核病患病率和利芬素耐药性建立了基线.
- 低但目前的利芬辛耐药率需要持续监测和早期检测.
- 加强结核病监测系统对于加纳有效控制至关重要.
更多相关视频
相关概念视频
Pulmonary Tuberculosis V
527
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
527
Pulmonary Tuberculosis IV
468
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
468
Pulmonary Tuberculosis I
806
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
806
Pulmonary Tuberculosis III
899
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
899
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K

